Oncostatin M Triggers Brain Inflammation by Compromising Blood–Brain Barrier Integrity

The authors investigated oncostatin M (OSM)’s role in pathological events important for the neuro-inflammatory disorder multiple sclerosis (MS) and showed that OSM receptor expression was increased on circulating lymphocytes of MS patients, indicating their elevated responsiveness to OSM signaling.